Efficacy and safety of entecavir (ETV) vs. adefovir (ADV) in chronic hepatitis B (CHB) patients with evidence of hepatic decompensation: ETV-048 study

被引：0
|
作者：
Liaw, Y. F. [1 ]
Raptopoulou-Gigi, M. [2 ]
Cheinquer, H. [3 ]
Sarin, S. K. [4 ]
Tanwandee, T. [5 ]
Leung, N. [6 ]
Myers, R. P. [7 ]
Brown, R. S., Jr. [8 ]
Bialkowska, J.
Munafo, L.
Chen, Y. C.
Tang, S.
Cooney, E.
Dharane, P.
Newman, J.
机构：
[1] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Guishan, Taiwan
[2] Aristotle Univ Thessaloniki, Dept Internal Med, Thessaloniki, Greece
[3] Univ Fed Rio Grande do Sul, BR-90046900 Porto Alegre, RS, Brazil
[4] GB Pant Hosp, Dept Gastroenterol, Delhi, India
[5] Mahidol Univ, Siriraj Hosp, Dept Med, Bangkok 10700, Thailand
[6] Alice Ho Miu Ling Nethersole Hosp, Tai Po, Hong Kong, Peoples R China
[7] Univ Calgary, Liver Unit, Calgary, AB T2N 1N4, Canada
[8] Columbia Univ, Med Ctr, Ctr Liver Dis & Transp, New York, NY 10027 USA
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A125 / A125
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of substituting lamivudine (LVD) with entecavir (ETV) in chronic hepatitis B (CHB) patients in the public sector of Hong Kong
    Lee, K. K.
    Lee, V. W. Y.
    Yuan, Y.
    VALUE IN HEALTH, 2007, 10 (03) : A162 - A162
  • [42] Efficacy, safety and low resistance of three years therapy with adefovir dipivoxil (ADV) in Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Mao, Yimin
    Zeng, Minde
    Yao, Guangbi
    Gao, Zhiliang
    Hou, Jinlin
    Wang, Hao
    Barker, Keith F.
    Dixon, Jon S.
    HEPATOLOGY, 2006, 44 (04) : 699A - 699A
  • [43] Safety of two years therapy with adefovir dipivoxil (ADV) for Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Zeng, Min-De
    Mao, Yi-Min
    Lu, Wei-Lun
    Wang, Yu-Ming
    Wang, Yao-Zong
    Dixon, Jonathan S.
    Barker, Keith F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A105 - A106
  • [44] Efficacy of two years therapy with adefovir dipivoxil (ADV) in Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Zeng, Min-De
    Mao, Yi-Min
    Yao, Guang-Bi
    Xu, Dao-Zhen
    Hou, Jin-Lin
    Chen, Ya-Gang
    Dixon, Jonathan S.
    Barker, Keith F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A71 - A72
  • [45] Is antiviral treatment for chronic hepatitis B (CHB) in Asian patients associated with osteopenia/osteoporosis? A comparison study of tenofovir (TDF), entecavir (ETV) and untreated (UTx) patients
    Wei, Mike
    Le, An K.
    Nguyen, Pauline
    Zhang, Jian Q.
    Wong, Chris
    Wong, Clifford
    Chang, Matthew
    Nguyen, Mindie H.
    HEPATOLOGY, 2017, 66 : 516A - 517A
  • [46] EXCELLENT TREATMENT RESPONSE TO TENOFOVIR(TDF)MONOTHERAPY IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH PRIOR SUBOPTIMAL RESPONSE TO ENTECAVIR (ETV) MONOTHERAPY
    Pan, Calvin
    Hu, Ke-Qin
    HEPATOLOGY, 2008, 48 (04) : 725A - 725A
  • [47] Risk and Predictors of Mortality or Hepatocellular Carcinoma Among Entecavir- or Adefovir-Treated Chronic Hepatitis B Patients With Evidence of Hepatic Decompensation
    Tsai, Naoky
    Liaw, Yun-Fan
    Raptopoulou-Gigi, Maria
    Cheinquer, Hugo
    Sarin, Shiv Kumar
    Tanwandee, Tawesak
    Leung, Nancy
    Peng, Cheng-Yuan
    Myers, Robert P.
    Brown, Robert S.
    Bialkowska, Jolanta
    Tang, Shijie
    Cooney, Elizabeth L.
    GASTROENTEROLOGY, 2010, 138 (05) : S831 - S831
  • [48] Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)
    Manns, M.
    Shouval, D.
    Akarca, U. S.
    Hatzis, G.
    Kitis, G.
    Zink, R.
    Zhu, J.
    Brett-Smith, H.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S86 - S86
  • [49] RISK AND PREDICTORS OF MORTALITY OR HEPATOCELLULAR CARCINOMA AMONG ENTECAVIR- OR ADEFOVIR-TREATED CHRONIC HEPATITIS B PATIENTS WITH EVIDENCE OF HEPATIC DECOMPENSATION
    Liaw, Y. -F.
    Raptopoulou-Gigi, M.
    Cheinquer, H.
    Sarin, S. K.
    Tanwandee, T.
    Leung, N.
    Peng, C. -Y.
    Myers, R. P.
    Brown, R. S., Jr.
    Tsai, N.
    Bialkowska, J.
    Tang, S.
    Cooney, E.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S390 - S391
  • [50] Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)
    Hadziyannis, S
    Tassopoulos, N
    Chang, TT
    Heathcote, J
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Chen, SS
    Arterburn, S
    Ma, J
    Xiong, S
    Wollman, M
    James, C
    Currie, G
    Brosgart, CL
    JOURNAL OF HEPATOLOGY, 2004, 40 : 17 - 17
12345